Definition
Bachem Holding AG is a Swiss‑based life‑science company that specializes in the research, development, and manufacturing of peptide‑based products and related custom‑manufacturing services for the pharmaceutical, biotechnology, and diagnostic sectors.
Overview
Founded in 1971, Bachem is headquartered in St. Gallen, Switzerland, and is publicly listed on the SIX Swiss Exchange. The company operates multiple production facilities equipped for Good Manufacturing Practice (GMP) compliant synthesis of peptides, amino acids, and related compounds. Its business model combines in‑house research and development with contract manufacturing services, serving global pharmaceutical and biotech customers. Bachem’s product portfolio includes custom‑synthesized peptides, peptide libraries, stable isotope‑labeled peptides, and ready‑to‑use peptide reagents for research and clinical applications.
Etymology/Origin
The name “Bachem” derives from the surname of the company’s founding family. The use of “Holding” denotes its structure as a parent corporation that oversees subsidiary operations focused on manufacturing, sales, and research.
Characteristics
- Core Competency: Large‑scale, high‑purity peptide synthesis using solid‑phase and solution‑phase technologies.
- Regulatory Compliance: Facilities are certified to GMP standards and meet regulatory requirements for pharmaceutical manufacturing in major markets (e.g., FDA, EMA).
- Global Reach: While manufacturing sites are located primarily in Europe, Bachem serves an international clientele through a network of sales and technical support offices.
- R&D Focus: The company maintains an internal research program aimed at developing novel peptide chemistries, analytical methods, and process optimizations.
- Financial Structure: As a publicly traded entity, Bachem reports its financial performance annually and is subject to Swiss corporate governance regulations.
Related Topics
- Peptide synthesis and solid‑phase peptide chemistry
- Contract manufacturing organizations (CMOs) in the pharmaceutical industry
- Biotechnology and biopharmaceutical manufacturing
- Swiss pharmaceutical and biotech sector
- Good Manufacturing Practice (GMP) regulations
Note: The information presented reflects established, publicly available data about Bachem Holding AG.